GNE Myopathy

Clinical Research/Studies

Are there clinical trials or research for GNE myopathy?

As of March 2016, there are several clinical trials looking at possible treatments for GNE myopathy (inclusion body myopathy 2 or IBM2). A complete list of current studies can be found by visiting and searching for inclusion body myopathy 2.

In March of 2016 there were at least two ongoing natural history studies. A natural history study allows scientists to track what types of symptoms people with IBM2 are experiencing to get a more complete picture of the disorder. GnemDMP Disease Monitoring Program ( is a program established to help understand how Inclusion Body Myopathy Type 2 affects people and help researchers better understand the condition to help find potential treatments. There is a patient part - an online registry, and a physician part - a Natural History Study. The link for the Natural History Study is:

Another Natural History Study is being conducted by the National Human Genome Research Institute (NHGRI), in collaboration with Therapeutics for Rare and Neglected Diseases (TRND). Information can be found at

Antidote also offers a handy tool to find clinical trials.

Show More Content Like This

More Clinical Research/Studies Content

How can I donate money to GNE Myopathy?

How can I donate money to GNE Myopathy?

You can contact groups for patients that support research into a cure for GNE myopathy (inclusion body myopathy 2 (IBM2)) and ask how to donate money to further research:

Neuromuscular Disease Foundation

Muscular Dystrophy Association (MDA)

The Myositis Association

  • Phone: 800-821-7356 (toll-free) or 703-299-4850
  • Email:
  • Website:

Muscular Dystrophy UK

Advancement of Research for Myopathies (ARM)

TREAT-NMD Neuromuscular Network

Sephardic Health Organization for Referral and Education (SHORE)

Patients Association for Distal Myopathies (PADM)


We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me